Guidelines Development

BIA has recently had significant involvement in the production of the following Guidelines:

NICE

BIA is a respondent to all infection related consultations conducted by NICE. We also supply experts to sit on relevant Committees associated with such guidelines.

Seronegative arthritides
Drug allergies
Antibiotics in neonatal infections (Quality Standard)
Hepatitis B
Urinary tract infection in children Cholelithiasis and cholecystitis

Other Bodies

Standardised Microbiology Investigations and Syndromic Algorithms (various consultations for SMI Working Groups)
EPIC 3

Guidelines Currently In Preparation

Bone & Joint Infections Guidelines (Infection Prevention & Control)
Toxigenic Staphylococcal Infections
DH MRSA Screening Policy
Norovirus Guidelines due for review in 2016

BIA has also met with BSAC, HIS and IPS and agreed to work together on NICE accredited revised MRSA guidelines with a view to establishing a permanent NICE accredited guidelines production system.